Evidence map›Paper›PMID 33332366›Full record

ArticlePLoS neglected tropical diseases2020

Zika and dengue but not chikungunya are associated with Guillain-Barré syndrome in Mexico: A case-control study.

Israel Grijalva, Concepción Grajales-Muñiz, César González-Bonilla, Victor Hugo Borja-Aburto, Martín Paredes-Cruz, José Guerrero-Cantera, Joaquín González-Ibarra, Alfonso Vallejos-Parás, Teresita Rojas-Mendoza, Clara Esperanza Santacruz-Tinoco and 16 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. [Epidemiological surveillance at IMSS: a review of institutional successes].Revista medica del Instituto Mexicano del Seguro Social · 2025
    Article
  5. Flaviviruses-Induced Neurological Sequelae.Pathogens (Basel, Switzerland) · 2024
    Review
  6. Guillain-Barré syndrome.Nature reviews. Disease primers · 2024
    Article
  7. [Dengue, rabies and measles in the post-COVID-19 pandemic era].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Article
  8. Article
  9. Central nervous system infections in the tropics.Current opinion in infectious diseases · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Nervous System Manifestations of Arboviral Infections.Current tropical medicine reports · 2022
    Review
  14. Article
  15. Article
  16. Observational
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 1 institution in 1 country.

Israel GrijalvaMedical Research Unit for Neurological Diseases, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.ORCID 0000-0002-1860-7594
Concepción Grajales-MuñizDivision of Epidemiological Surveillance of Communicable Diseases, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
César González-BonillaDivision of Surveillance Laboratories and Epidemiological Research, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Victor Hugo Borja-AburtoPrimary Health-Care Unit. Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Martín Paredes-CruzMedical Research Unit for Neurological Diseases, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
José Guerrero-CanteraMedical Research Unit for Neurological Diseases, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Joaquín González-IbarraDivision of Surveillance Laboratories and Epidemiological Research, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Alfonso Vallejos-ParásDivision of Epidemiological Surveillance of Communicable Diseases, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Teresita Rojas-MendozaDivision of Epidemiological Surveillance of Communicable Diseases, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico.ORCID 0000-0002-6658-1739
Clara Esperanza Santacruz-TinocoCentral Laboratory of Epidemiology, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Porfirio Hernández-BautistaDivision of Epidemiological Surveillance of Communicable Diseases, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Lumumba Arriaga-NietoDivision of Epidemiological Surveillance of Communicable Diseases, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Ma Guadalupe Garza-SagásteguiMedical Provisions for the State Nuevo León, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.
Ignacio Vargas-RamosUMAE Hospital de Especialidades No. 25, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.
Ana Sepúlveda-NúñezUMAE Hospital de Especialidades No. 25, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.
Omar Israel Campos-VillarrealUMAE Hospital de Especialidades No. 25, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.
Roberto Corrales-PérezMedical Epidemiological Assistance Coordination of the State of Nuevo León, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.
Mallela Azuara-CastilloHospital General de Zona No. 33, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.
Elsa Sierra-GonzálezHospital General de Zona No. 33, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.ORCID 0000-0002-3697-3934
José Alfonso Meza-MedinaHospital General de Zona No. 33, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.
Bernardo Martínez-MiguelCentral Laboratory of Epidemiology, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Gabriela López-BecerrilMedical Research Unit for Neurological Diseases, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Jessica Ramos-OrozcoHospital General Regional No.1, Instituto Mexicano del Seguro Social, Tijuana, Baja California, Mexico.
Tomás Muñoz-GuerreroHospital General Regional No.1, Instituto Mexicano del Seguro Social Orizaba, Veracruz, Mexico.
María Soledad Gutiérrez-LozanoHospital General Regional No.1, Instituto Mexicano del Seguro Social Orizaba, Veracruz, Mexico.
Arlette Areli Cervantes-OcampoHospital General de Zona y Medicina Familiar No. 36, Instituto Mexicano del Seguro Social, Coatzacoalcos, Veracruz, Mexico.
Mexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Zika, dengue and chikungunya viruses (ZIKV, CHIKV and DENV) are temporally associated with neurological diseases, such as Guillain-Barré syndrome (GBS). Because these three arboviruses coexist in Mexico, the frequency and severity of GBS could theoretically increase. This study aims to determine the association between these arboviruses and GBS in a Mexican population and to establish the clinical characteristics of the patients, including the severity of the infection. A case-control study was conducted (2016/07/01-2018/06/30) in Instituto Mexicano del Seguro Social (Mexican Social Security Institute) hospitals, using serum and urine samples that were collected to determine exposure to ZIKV, DENV, CHIKV by RT-qPCR and serology (IgM). For the categorical variables analysis, Pearson's χ2 or Fisher exact tests were used, and the Mann-Whitney U test for continuous variables. To determine the association of GBS and viral infection diagnosis through laboratory and symptomatology before admission, we calculated the odds ratio (OR) and 95% confidence intervals (95%CI) using a 2x2 contingency table. A p-value ≤ 0.05 was considered as significant. Ninety-seven GBS cases and 184 controls were included. The association of GBS with ZIKV acute infection (OR, 8.04; 95% CI, 0.89-73.01, p = 0.047), as well as laboratory evidence of ZIKV infection (OR, 16.45; 95% CI, 2.03-133.56; p = 0.001) or Flavivirus (ZIKV and DENV) infection (OR, 6.35; 95% CI, 1.99-20.28; p = 0.001) was observed. Cases of GBS associated with ZIKV demonstrated a greater impairment of functional status and a higher percentage of mechanical ventilation. According to laboratory results, an association between ZIKV or ZIKV and DENV infection in patients with GBS was found. Cases of GBS associated with ZIKV exhibited a more severe clinical picture. Cases with co-infection were not found.

Indexed as

AdultCase-Control StudiesChikungunya FeverDengueFemaleGuillain-Barre SyndromeHumansMaleMexicoMiddle AgedRisk FactorsYoung AdultZika Virus Infection

Identifiers

PMID33332366
PMCPMC7775118
OpenAlexW3111599121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.